J.P. Morgan Private Wealth Advisors’s Celldex Therapeutics CLDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-738
| Closed | -$31K | – | 1303 |
|
|
2017
Q4 | $31K | Hold |
738
| – | – | ﹤0.01% | 1273 |
|
|
2017
Q3 | $31K | Hold |
738
| – | – | ﹤0.01% | 1227 |
|
|
2017
Q2 | $27K | Sell |
738
-375
| -34% | -$13.7K | ﹤0.01% | 1220 |
|
|
2017
Q1 | $59K | Sell |
1,113
-1
| -0.1% | -$53 | ﹤0.01% | 1306 |
|
|
2016
Q4 | $59K | Buy |
1,114
+2
| +0.2% | +$106 | ﹤0.01% | 1218 |
|
|
2016
Q3 | $68K | Sell |
1,112
-105
| -9% | -$6.42K | ﹤0.01% | 1200 |
|
|
2016
Q2 | $81K | Buy |
1,217
+218
| +22% | +$14.5K | ﹤0.01% | 1216 |
|
|
2016
Q1 | $56K | Sell |
999
-155
| -13% | -$8.69K | ﹤0.01% | 1183 |
|
|
2015
Q4 | $271K | Sell |
1,154
-367
| -24% | -$86.2K | ﹤0.01% | 910 |
|
|
2015
Q3 | $240K | Buy |
1,521
+460
| +43% | +$72.6K | ﹤0.01% | 864 |
|
|
2015
Q2 | $401K | Buy |
+1,061
| New | +$401K | ﹤0.01% | 754 |
|